Detalles de la búsqueda
1.
Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers.
Proc Natl Acad Sci U S A
; 119(29): e2123134119, 2022 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858357
2.
Feasibility Study of Transarterial Chemotherapy Followed by Chemoembolization for Recurrent Breast Cancer.
J Vasc Interv Radiol
; 35(4): 516-522, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38154745
3.
Strontium-89 plus zoledronic acid versus zoledronic acid for patients with painful bone metastatic breast cancer.
J Bone Miner Metab
; 40(6): 998-1006, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36042056
4.
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial).
Breast Cancer Res Treat
; 186(1): 135-147, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33259001
5.
Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).
Int J Clin Oncol
; 26(7): 1229-1236, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33891194
6.
Ocean currents and herbivory drive macroalgae-to-coral community shift under climate warming.
Proc Natl Acad Sci U S A
; 115(36): 8990-8995, 2018 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30126981
7.
Upregulation of S100A10 in metastasized breast cancer stem cells.
Cancer Sci
; 111(12): 4359-4370, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32976661
8.
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
N Engl J Med
; 376(22): 2147-2159, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28564564
9.
Physical activity among patients with breast cancer receiving aromatase inhibitors is associated with bone health: a cross-sectional observational study.
Breast Cancer Res Treat
; 182(1): 187-193, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32399742
10.
Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
Jpn J Clin Oncol
; 49(6): 545-553, 2019 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796835
11.
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.
Breast Cancer Res Treat
; 171(3): 675-683, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29971625
12.
Expression of programmed death-1 in sentinel lymph nodes of breast cancer.
J Surg Oncol
; 117(6): 1131-1136, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193094
13.
Hormonal Therapy Resistant Estrogen-receptor Positive Metastatic Breast Cancer Cohort (HORSE-BC) Study : Current Status of Treatment Selection in Japan.
Acta Med Okayama
; 72(4): 369-374, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30140084
14.
Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.
Cancer Sci
; 108(5): 987-994, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28256066
15.
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study.
Invest New Drugs
; 35(6): 791-799, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28660549
16.
Improving the interpretability of climate landscape metrics: An ecological risk analysis of Japan's Marine Protected Areas.
Glob Chang Biol
; 23(10): 4440-4452, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28211249
17.
Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer.
BMC Cancer
; 17(1): 589, 2017 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28851309
18.
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).
Int J Clin Oncol
; 27(11): 1793, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166110
19.
A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer.
Jpn J Clin Oncol
; 46(5): 407-14, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26917603
20.
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).
Int J Clin Oncol
; 26(7): 1237, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34043103